These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18997142)

  • 1. Compatibility of risedronate sodium tablets with food thickeners.
    Dansereau RJ; Crail DJ
    Am J Health Syst Pharm; 2008 Nov; 65(22):2133-6. PubMed ID: 18997142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extemporaneous procedures for dissolving risedronate tablets for oral administration and for feeding tubes.
    Dansereau RJ; Crail DJ
    Ann Pharmacother; 2005 Jan; 39(1):63-7. PubMed ID: 15590875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a micellar high-performance liquid chromatographic method for determination of risedronate in raw material and in a pharmaceutical formulation: application to stability studies.
    Walash M; Metwally M; Eid M; El-Shaheny R
    J AOAC Int; 2010; 93(4):1228-35. PubMed ID: 20922956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel automated hydrophilic interaction liquid chromatography method using diode-array detector/electrospray ionization tandem mass spectrometry for analysis of sodium risedronate and related degradation products in pharmaceuticals.
    Bertolini T; Vicentini L; Boschetti S; Andreatta P; Gatti R
    J Chromatogr A; 2014 Oct; 1365():131-9. PubMed ID: 25242223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.
    Walker AD; Adachi JD
    Curr Med Res Opin; 2011 Sep; 27(9):1749-54. PubMed ID: 21781014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects.
    Perkins AC; Blackshaw PE; Hay PD; Lawes SC; Atherton CT; Dansereau RJ; Wagner LK; Schnell DJ; Spiller RC
    Clin Ther; 2008 May; 30(5):834-44. PubMed ID: 18555931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an ion-pair reversed-phase HPLC method with indirect UV detection for determination of phosphates and phosphites as impurities in sodium risedronate.
    Breuzovska K; Dimitrovska A; Kitanovski Z; Petrusevska J; Ribarska JT; Jolevska ST
    J AOAC Int; 2010; 93(4):1113-20. PubMed ID: 20922941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence study of two risedronate sodium film-coated tablet formulations in healthy volunteers.
    Simanjuntak R; Setiawati E; Yunaidi DA; Handayani LR; Setiawati A; Utami BS; Rosa TA; Sholeh AB
    Drug Res (Stuttg); 2014 Mar; 64(3):136-40. PubMed ID: 24002927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risedronate-loaded Eudragit S100 microparticles formulated into tablets.
    Velasquez AA; Mattiazzi J; Ferreira LM; Pohlmann L; Silva CB; Rolim CM; Cruz L
    Pharm Dev Technol; 2014 May; 19(3):263-8. PubMed ID: 23506303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations.
    Kyriakides D; Panderi I
    Anal Chim Acta; 2007 Feb; 584(1):153-9. PubMed ID: 17386598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of floating risedronate sodium-Gelucire 43/01 formulations.
    Chauhan B; Shimpi S; Mahadik KR; Paradkar A
    Drug Dev Ind Pharm; 2005 Oct; 31(9):851-60. PubMed ID: 16305996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water.
    Perkins AC; Wilson CG; Frier M; Blackshaw PE; Dansereau RJ; Vincent RM; Wenderoth D; Hathaway S; Li Z; Spiller RC
    Int J Pharm; 2001 Jul; 222(2):295-303. PubMed ID: 11427359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence.
    Ringe JD; van der Geest SA; Möller G
    Drugs Aging; 2006; 23(7):569-78. PubMed ID: 16930085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Xanthan Gum-based Food Thickeners Reduce Disintegration Time of Medical and OTC Loxoprofen Sodium Tablets].
    Kawahara M; Moriyama M; Fukatsu M; Ando M; Watanabe N
    Yakugaku Zasshi; 2024 Feb; 144(2):231-237. PubMed ID: 38008462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects on tablet disintegration of solvents used to dissolve food thickeners.
    Matsuo T; Sasaki H; Tomita T; Sadzuka Y
    J Texture Stud; 2021 Jun; 52(3):380-388. PubMed ID: 33495997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations.
    Perkins AC; Wilson CG; Frier M; Vincent RM; Blackshaw PE; Dansereau RJ; Juhlin KD; Bekker PJ; Spiller RC
    Int J Pharm; 1999 Sep; 186(2):169-75. PubMed ID: 10486435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Food Thickeners on the Disintegration, Dissolution, and Drug Activity of Rapid Oral-disintegrating Tablets].
    Tomita T; Kohda Y; Kudo K
    Yakugaku Zasshi; 2018; 138(3):353-356. PubMed ID: 29503428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications.
    Dansereau RJ; Crail DJ; Perkins AC
    Curr Med Res Opin; 2008 Apr; 24(4):1137-45. PubMed ID: 18334082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.
    Hausman DS; Cambron RT; Sakr A
    Int J Pharm; 2005 Aug; 299(1-2):19-33. PubMed ID: 15979262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Food Thickeners on the Inhibitory Effect of Voglibose Oral-disintegrating Tablets on Post-prandial Elevation of Blood Sugar Levels.
    Tomita T; Goto H; Sumiya K; Yoshida T; Tanaka K; Kohda Y
    Yakugaku Zasshi; 2016; 136(8):1171-6. PubMed ID: 27477734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.